首页> 外文期刊>The Journal of dermatological treatment >An open-label prospective clinical study to assess the efficacy of increasing levocetirizine dose up to four times in chronic spontaneous urticaria not controlled with standard dose
【24h】

An open-label prospective clinical study to assess the efficacy of increasing levocetirizine dose up to four times in chronic spontaneous urticaria not controlled with standard dose

机译:开放标签的前瞻性临床研究,评估Levocetirizine剂量高达4次不受标准剂量的慢性自发性荨麻疹的疗效

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objective: The EAACI/GA(2)LEN/EDF/WAO recommendation of increasing antihistamines' dose up to four times in urticaria not adequately controlled with the standard dose is largely based on expert opinion. The objective of this study is to test the current urticaria guidelines of up-dosing antihistamines as second-line treatment.
机译:目的:EAACI / GA(2)LEN / EDF / WAO建议增加抗炎症患者在荨麻疹中不足4次,没有充分控制标准剂量,主要基于专家意见。 本研究的目的是测试目前荨麻疹的血清菌抗组胺药指南作为二线治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号